Evidence map›Paper›PMID 31941241›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2019

[Abnormal expression of Wnt3a and inhibiting role of its molecular-targeted intervening in hepatocellular carcinoma].

W L Sai, M Yao, W J Zheng, M N Wu, J Y Sun, L H Pan, Z Z Dong, D F Yao

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

W L SaiResearch Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China.
M YaoImmunology Department, Medicine School of Nantong University, Nantong 226001, China.
W J ZhengResearch Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China.
M N WuResearch Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China.
J Y SunResearch Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China.
L H PanResearch Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China.
Z Z DongResearch Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China.
D F YaoResearch Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China.
Affiliated Hospital of Nantong University · CNNantong University · CN

Funding

Key Research & Developing Program of Jiangsu BE2016698Nantong Science & Technology Project MS12017014-4National Natural Science Foundation of China 81673241, 81702419, 31872738
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsCarcinoma, HepatocellularCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticHep G2 CellsHumansLiver NeoplasmsMiceMice, NudeWnt3A ProteinWnt3A ProteinWnt3a protein, mouseCarcinoma, hepatocellularTargeted therapyWnt3a

Identifiers

PMID31941241
PMCPMC12769339
OpenAlexW3011187878

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.